Vitamin E now a focus of the investigation into some vaping illnesses

Lifestyle

Vitamin E acetate is now a focus of the investigation into vaping-related respiratory illnesses that have sickened 34 people in New York, state health officials say.

As of Thursday afternoon, there have been 361 confirmed or suspected cases reported by state health departments nationwide. Two people have died, one in Illinois and the other in Oregon.

On Thursday, the New York State Department of Health said lab tests showed extremely high levels of vitamin E acetate in nearly all of the analyzed samples of products that contained cannabis.

Vitamin E acetate was not found in the nicotine products tested.

The compound is a commonly available nutritional supplement that is not known to be harmful when taken as a vitamin or applied to skin, according to the New York State Department of Health.

“We urge the public to be vigilant about any vaping products that they or any family members may be using and to immediately contact their health care provider if they develop any unusual symptoms,” New York Health Commissioner Dr. Howard Zucker wrote in a news release. “Vaping of unknown substances is dangerous, and we continue to explore all options to combat this public health issue.”

The Food and Drug Administration is now testing more than 100 samples from states, and has not ruled out other contaminants that may be at play, including nicotine, THC and other cannabinoids, along with cutting agents/diluents and other additives, pesticides, opioids, poisons and toxins.

“No one substance, including vitamin E acetate, has been identified in all of the samples tested,” an FDA spokesman wrote in an email to NBC News. “Importantly, identifying any compounds that are present in the samples will be one piece of the puzzle but will not necessarily answer questions about causality.”

Zeroing in on a diagnosis

A number of the recent lung illnesses have been diagnosed as lipoid pneumonia, a condition that occurs when inflammatory cells with abnormally high levels of fatty substances called lipids collect in the lungs.

“We certainly know what causes lipoid pneumonia, which is oil inhalation,” said Thomas Eissenberg, a co-director of the Center for the Study of Tobacco Products at Virginia Commonwealth University.

Eissenberg has been studying alternative tobacco products, including e-cigarettes, since the late 1990s, and recently worked toward developing methods for evaluating new tobacco products under a grant from the FDA and National Institute on Drug Abuse.

He said there are two ways for a person to develop lipoid pneumonia.

“You can get it because you’ve had some physical injury to your lung whereas your own body fat enters the lung, gets treated as a foreign invader and an immune response is mounted,” he said.

“Or you inhale oil.”

Inhaling oil

This is not the first time vitamin E oil has been implicated in a vaping-related lung illness.

In 2000, Dr. Dilini Vethanayagam was a resident physician at McMaster University Medical Center in Ontario, Canada. One of her patients was a 30-year-old woman who appeared to have a bad infection. She was having trouble breathing, and was coughing, fatigued and vomiting, and had a fever and diarrhea.

Tests revealed the woman had lipoid pneumonia. But there was no explanation as to what caused it.

That’s when Vethanayagam dug deeper into the woman’s history. The woman admitted to inhaling home brews of marijuana oil made with either petroleum jelly or vitamin E oil.

Vethanayagam, now an associate professor of respirology at the University of Alberta, said she was fascinated by the case. “She didn’t have to have this happen. It was just from inhaling this [oil] repeatedly,” Vethanayagam told NBC News.

She and fellow physicians published the case report in the Canadian Respiratory Journal in the summer of 2000.

Twelve years later, the first vaping-related pneumonia case showed up in the medical literature in the U.S.

In 2012, Dr. Lindsay Leither, then a resident at Legacy Good Samaritan Medical Center in Portland, Oregon, treated a 42-year-old woman with symptoms similar to the Canadian case: shortness of breath, cough and fever.

The woman had been to the emergency room several times before with the same symptoms, and had been treated with antibiotics.

But her illness didn’t go away. Tests for viral and bacterial infections came back negative, leaving Leither stumped.

Imaging and samples taken from the woman’s lungs revealed lipoid pneumonia.

“Lipoid pneumonia was mostly found in the pediatric population from little kids accidentally aspirating petroleum jelly that parents were putting around noses or the mouth,” Leither, who is now a pulmonary and critical care physician with Intermountain Healthcare in Salt Lake City, told NBC News.

“It wasn’t very commonly seen in adults, so that’s what got us thinking: What was this person’s exposure that could have contributed?” she recalled.

A dive into the patient’s history revealed her symptoms began seven months before, about the same time she began using nicotine e-cigarettes. The woman had not vaped marijuana products.